H
H: VONDRASEK MARK R discloses securities transactions
VONDRASEK MARK R reported Exercise or conversion in Hyatt Hotels Corp: 3482 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 7 transaction entries.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
H
VONDRASEK MARK R reported Exercise or conversion in Hyatt Hotels Corp: 3482 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 7 transaction entries.
KMTS
Moran Timothy P. reported Sale in KESTRA MEDICAL TECHNOLOGIES, LTD.: 3192 units of Common Shares, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
OBT
Ruhl Joseph A reported Sale in Orange County Bancorp, Inc. /DE/: 1923 units of Common Stock, dated 2026-11-05. The full Form 4 contains 1 transaction entry.
H
HOPLAMAZIAN MARK SAMUEL reported Sale in Hyatt Hotels Corp: 22132 units of Class A Common Stock, dated 2026-11-03. The full Form 4 contains 7 transaction entries.
PRCH
Pickerill Alan R reported Exercise or conversion in Porch Group, Inc.: 5000 units of Common Stock, dated 2026-11-03. The full Form 4 contains 4 transaction entries.
BXMT
Johnson Timothy Steven reported Purchase in BLACKSTONE MORTGAGE TRUST, INC.: 90000 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
BXMT
NASSAU HENRY N reported Purchase in BLACKSTONE MORTGAGE TRUST, INC.: 10000 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
H
Egan Margaret C. reported Sale in Hyatt Hotels Corp: 1100 units of Class A Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
SPWH
Stone Paul reported Tax/exercise withholding in SPORTSMAN'S WAREHOUSE HOLDINGS, INC.: 47674 units of Common Stock, dated 2026-11-01. The full Form 4 contains 1 transaction entry.
FOX
CAREY CHASE reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
FOX
Ryan Paul D reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
FOX
HERNANDEZ ROLAND A reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
IBO
Macko Todd D reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
FOX
Burck William A reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
AMP
WILLIAMS CHRISTOPHER J reported Grant or award in AMERIPRISE FINANCIAL INC: 40.8513 units of Phantom Stock (Retainer Deferral) (derivative), dated 2026-11-03. The full Form 4 contains 1 transaction entry.
ETRA
GORDON CARL L reported Purchase in Electra Therapeutics, Inc.: 24313 units of Common Stock, dated 2026-11-03. The full Form 4 contains 10 transaction entries.
IBO
Grady Jason reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
FOX
Johnson Margaret L reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
FOX
Abbott Anthony J reported Grant or award in Fox Corp: 3230 units of Deferred Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
IBO
Chan Heng Fai Ambrose reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
IBO
Brownell Elise reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
IBO
Keene David K reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
IBO
Sims Melissa Kaye reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.
IBO
Hibbert Castel Berisford reported 4,170 shares of Common Stock in IMPACT BIOMEDICAL INC. as grants or awards dated 2026-10-07. The Form 4 was disclosed on Nov 5, 2026. These were stock awards, not open-market purchases.